Leland Sumrall, PHARMD in Angie, LA - Pharmacist

Leland Sumrall, PHARMD is a Pharmacist based in Angie, Louisiana. Leland Sumrall is licensed to practice in Louisiana (license number 17192) and his current practice location is 30304 Highway 21, Angie, Louisiana. He can be reached at his office (for appointments etc.) via phone at (985) 986-4433.

NPI number for Leland Sumrall is 1578070751 and his current mailing address is 30304 Highway 21, Angie, Louisiana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1578070751.

Contact Information

	Leland Sumrall, PHARMD
	30304 Highway 21, Angie, LA 70426-4264
	(985) 986-4433
	(985) 986-4900

Healthcare Provider's Profile

Full Name	Leland Sumrall
Gender	Male
Speciality	Pharmacist
Location	30304 Highway 21, Angie, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1578070751
Provider Enumeration Date: 01/09/2018
Last Update Date: 01/09/2018

Medical Identifiers

Medical identifiers for Leland Sumrall such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578070751	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	17192 (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Leland Sumrall is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Leland Sumrall, PHARMD 30304 Highway 21, Angie, LA 70426-4264 Ph: (985) 986-4433	Leland Sumrall, PHARMD 30304 Highway 21, Angie, LA 70426-4264 Ph: (985) 986-4433

News Archive

Applied BioCode's novel BMB technology to be presented at Biodetection Technologies 2010 Conference

Applied BioCode, Inc. announced today a presentation to be given on their Barcoded Magnetic Beads technology at the Biodetection Technologies 2010 Conference in Arlington, Virginia. The presentation is titled "Multiplexed Assays Go Digital" and will be given by Dr. Winston Ho, President at Applied BioCode, on June 18, 2010.

Roxane announces FDA approval for Anastrozole Tablets ANDA

Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1mg by the U.S. Food and Drug Administration. The product is available in bottles of 30 for immediate shipment to wholesalers and pharmacies nationwide.

Phase IIa clinical data of EHT 0202 released

Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit's lead candidate for the treatment of Alzheimer's disease, is safe and generally well tolerated in patients and that it could potentially enhance cognition in Alzheimer's disease patients.

Specialized parental training helps improve quality of life for preschool children with ADHD

Research findings from Aarhus University and the Central Denmark Region's Child and Adolescent Psychiatric Centre show that quality of life is poorer for preschool children with ADHD compared to children from the control population.

Study finds significant links between depression, poor dietary quality and high BMI

In a study published in the Journal of the Academy of Nutrition and Dietetics, researchers from the RAND Corporation report that for people receiving food assistance there are significant links between depression, poor dietary quality, and high body mass index (BMI).

Leland Sumrall, PHARMD - Pharmacist in Angie, LA